Ownership history in Bruce & Co., Inc. · 25 quarters on record
This page tracks every 13F SEC filing in which Bruce & Co., Inc. reported a position in Fate Theraputics (FATE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 729,188 | — | 0% | 0.22% | $716K | $0.98 |
| 2025 Q3 | ADDED | 729,188 | +300,000 | +69.9% | 0.28% | $919K | $1.26 |
| 2025 Q2 | REDUCED | 429,188 | -120,812 | -22.0% | 0.16% | $481K | $1.12 |
| 2025 Q1 | ADDED | 550,000 | +200,000 | +57.1% | 0.14% | $434K | $0.79 |
| 2024 Q4 | UNCHANGED | 350,000 | — | 0% | 0.19% | $578K | $1.65 |
| 2024 Q3 | ADDED | 350,000 | +50,000 | +16.7% | 0.36% | $1.2M | $3.50 |
| 2024 Q2 | ADDED | 300,000 | +157,000 | +109.8% | 0.32% | $984K | $3.28 |
| 2024 Q1 | UNCHANGED | 143,000 | — | 0% | 0.35% | $1.0M | $7.34 |
| 2023 Q4 | REDUCED | 143,000 | -57,000 | -28.5% | 0.19% | $535K | $3.74 |
| 2023 Q3 | UNCHANGED | 200,000 | — | 0% | 0.14% | $424K | $2.12 |
As of 2025 Q4 — sorted by position size